Clinical research in cardiology supplements

Keyphrases

Publications

volume 14, number Suppl 1, 2019

U Julius, S Tselmin, U Schatz, S Fischer, S R Bornstein
Lipoprotein(a)-an interdisciplinary challenge. Clinical research in cardiology supplements 14 (Suppl 1) (2019)
U Julius, S Tselmin, U Schatz, S Fischer, S R Bornstein
Lipoprotein(a) and proprotein convertase subtilisin/kexin type 9 inhibitors. Clinical research in cardiology supplements 14 (Suppl 1) (2019)
Norbert Weiss, Ulrich Julius
Lipoprotein(a) apheresis in patients with peripheral arterial disease: rationale and clinical results. Clinical research in cardiology supplements 14 (Suppl 1) (2019)
Florian Kronenberg
Prediction of cardiovascular risk by Lp(a) concentrations or genetic variants within the LPA gene region. Clinical research in cardiology supplements 14 (Suppl 1) (2019)
Anja Vogt
Lipoprotein(a)-antisense therapy. Clinical research in cardiology supplements 14 (Suppl 1) (2019)
Alexander Heinrich Nave, Arnold von Eckardstein
Is lipoprotein(a) a risk factor for ischemic stroke and venous thromboembolism? Clinical research in cardiology supplements 14 (Suppl 1) (2019)
Reinhard Klingel, Andreas Heibges, Cordula Fassbender
Lipoprotein(a) and mortality-a high risk relationship. Clinical research in cardiology supplements 14 (Suppl 1) (2019)
V J J Schettler, C L Neumann, C Peter, T Zimmermann, U Julius, B Hohenstein, E Roeseler, F Heigl, P Grützmacher, H Blume, R Klingel, A Vogt, null null
Lipoprotein apheresis is an optimal therapeutic option to reduce increased Lp(a) levels. Clinical research in cardiology supplements 14 (Suppl 1) (2019)
K P Mellwig, A Vogt
Lipoprotein(a). Clinical research in cardiology supplements 14 (Suppl 1) (2019)

volume 12, number Suppl 1, 2018

Klaus-Peter Mellwig
Editorial Lp(a) - the underestimated cardiovascular risk factor. Clinical research in cardiology supplements 12 (Suppl 1) (2018)

2017

Detlev Willemsen, C Cordes, B Bjarnason-Wehrens, E Knoglinger, E Langheim, R Marx, N Reiss, T Schmidt, A Workowski, P Bartsch, C Baumbach, C Bongarth, H Phillips, R Radke, M Riedel, S Schmidt, E Skobel, C Toussaint, J Glatz
[Rehabilitation standards for follow-up treatment and rehabilitation of patients with ventricular assist device (VAD)]. Clinical research in cardiology supplements (2017)
V J J Schettler, C L Neumann, C Peter, T Zimmermann, U Julius, E Roeseler, F Heigl, P Grützmacher, H Blume, A Vogt, null null
Erratum to: The German Lipoprotein Apheresis Registry (GLAR) - almost 5 years on. Clinical research in cardiology supplements (2017)
Hermann Reichenspurner
[Not Available]. Clinical research in cardiology supplements (2017)

volume 12, number Suppl 1, 2017

Franz Heigl, Reinhard Hettich, Erich Mauch, Reinhard Klingel, Cordula Fassbender
Lipoprotein(a)-hyperlipoproteinemia as cause of chronic spinal cord ischemia resulting in progressive myelopathy - successful treatment with lipoprotein apheresis. Clinical research in cardiology supplements 12 (Suppl 1) (2017)
Anja Vogt
Hyperlipoproteinaemia(a) - apheresis and emerging therapies. Clinical research in cardiology supplements 12 (Suppl 1) (2017)
Klaus-Peter Mellwig, Dieter Horstkotte, Frank van Buuren
Lipoprotein (a) and coronary heart disease - is there an efficient secondary prevention? Clinical research in cardiology supplements 12 (Suppl 1) (2017)
Reinhard Klingel, Andreas Heibges, Cordula Fassbender, null null
Prevention of cardiovascular complications in patients with Lp(a)-hyperlipoproteinemia and progressive cardiovascular disease by long-term lipoprotein apheresis according to German national guidelines. Clinical research in cardiology supplements 12 (Suppl 1) (2017)
Evelyn Orsó, Gerd Schmitz
Lipoprotein(a) and its role in inflammation, atherosclerosis and malignancies. Clinical research in cardiology supplements 12 (Suppl 1) (2017)
Bernd Hohenstein
Lipoprotein(a) in nephrological patients. Clinical research in cardiology supplements 12 (Suppl 1) (2017)
Rainer Schulz, Klaus-Dieter Schlüter
PCSK9 targets important for lipid metabolism. Clinical research in cardiology supplements 12 (Suppl 1) (2017)
Frank van Buuren, Dieter Horstkotte, Cornelius Knabbe, Dennis Hinse, Klaus Peter Mellwig
Incidence of elevated lipoprotein (a) levels in a large cohort of patients with cardiovascular disease. Clinical research in cardiology supplements 12 (Suppl 1) (2017)
V J J Schettler, C L Neumann, C Peter, T Zimmermann, U Julius, E Roeseler, F Heigl, P Grützmacher, H Blume, A Vogt, null null
The German Lipoprotein Apheresis Registry (GLAR) - almost 5 years on. Clinical research in cardiology supplements 12 (Suppl 1) (2017)
P Grützmacher, B Öhm, S Szymczak, C Dorbath, M Brzoska, C Kleinert
Primary and secondary prevention of cardiovascular disease in patients with hyperlipoproteinemia (a). Clinical research in cardiology supplements 12 (Suppl 1) (2017)

volume 10, 2015

Frank van Buuren, Julia Alexia Sommer, Tanja Kottmann, Dieter Horstkotte, Klaus Peter Mellwig
[Extracardiac manifestation of elevated lipoprotein(a) levels--cumulative incidence of peripheral arterial disease and stenosis of the carotid artery]. Clinical research in cardiology supplements 10 (2015)
Reinhard Klingel, Andreas Heibges, Cordula Fassbender
Lipoprotein apheresis results in plaque stabilization and prevention of cardiovascular events: comments on the prospective Pro(a)LiFe study. Clinical research in cardiology supplements 10 (2015)
Franz Heigl, Reinhard Hettich, Norbert Lotz, Harduin Reeg, Tobias Pflederer, Dirk Osterkorn, Klaus Osterkorn, Reinhard Klingel
Clinical benefit of long-term lipoprotein apheresis in patients with severe hypercholesterolemia or Lp(a)-hyperlipoproteinemia with progressive cardiovascular disease. Clinical research in cardiology supplements 10 (2015)
K-P Mellwig, C Schatton, B Biermann, T Kottmann, D Horstkotte, F van Buuren
[Lipoprotein(a): influence on cardiovascular manifestation]. Clinical research in cardiology supplements 10 (2015)
Volker J J Schettler, Class L Neumann, Christian Peter, Thomas Zimmermann, Ulrich Julius, Eberhard Roeseler, Franz Heigl, null null
Impact of the German Lipoprotein Apheresis Registry (DLAR) on therapeutic options to reduce increased Lp(a) levels. Clinical research in cardiology supplements 10 (2015)
Bilgen Kurt, Muhidien Soufi, Alexander Sattler, Juergen R Schaefer
Lipoprotein(a)-clinical aspects and future challenges. Clinical research in cardiology supplements 10 (2015)
P Grützmacher, C Kleinert, C Dorbath, B Öhm
Indications for apheresis as an ultima ratio treatment of refractory hyperlipidemias. Clinical research in cardiology supplements 10 (2015)
Dieter Horstkotte
[Editorial]. Clinical research in cardiology supplements 10 (2015)
Gerd Schmitz, Evelyn Orsó
Lipoprotein(a) hyperlipidemia as cardiovascular risk factor: pathophysiological aspects. Clinical research in cardiology supplements 10 (2015)

volume 7, 2013

Juergen R Schaefer, Bilgen Kurt, Alexander Sattler, Günter Klaus, Muhidien Soufi
Pharmacogenetic aspects in familial hypercholesterolemia with the special focus on FHMarburg (FH p.W556R). Clinical research in cardiology supplements 7 (2013)
Nils Ewald, Hans-Ulrich Kloer
Treatment options for severe hypertriglyceridemia (SHTG): the role of apheresis. Clinical research in cardiology supplements 7 (2013)
Peter Schuff-Werner, Sebastian Fenger, Peter Kohlschein
Role of lipid apheresis in changing times. Clinical research in cardiology supplements 7 (2013)
Peter Grützmacher, Claudius Kleinert
Lipid apheresis techniques: current status in Germany. Clinical research in cardiology supplements 7 (2013)
K-P Mellwig, E Pulawski, D Horstkotte, F van Buuren
Lipid apheresis: oxidative stress, rheology, and vasodilatation. Clinical research in cardiology supplements 7 (2013)
Prof Dr Med D Horstkotte
Lipid apheresis - last resort or selective therapeutic option? Proceedings of a symposium held in Bad Oeynhausen, Germany, October 7 - 8, 2011. Editorial. Clinical research in cardiology supplements 7 (2013)
Martin Canis, Franz Heigl, Markus Suckfuell
Fibrinogen/LDL apheresis is a promising rescue therapy for sudden sensorineural hearing loss. Clinical research in cardiology supplements 7 (2013)
Alfonso Ramunni, Paola Brescia, Giuseppina De Fino, Giovanni Piscopo, Loreto Gesualdo
Therapeutic apheresis in peripheral and retinal circulatory disorders. Clinical research in cardiology supplements 7 (2013)
Volker Schettler, C L Neumann, M Hulpke-Wette, G C Hagenah, E G Schulz, E Wieland, null null
Current view: indications for extracorporeal lipid apheresis treatment. Clinical research in cardiology supplements 7 (2013)
Frank van Buuren, Sven Kreickmann, Dieter Horstkotte, Tanja Kottmann, Klaus Peter Mellwig
HELP apheresis in hypercholesterolemia and cardiovascular disease: efficacy and adverse events after 8,500 procedures. Clinical research in cardiology supplements 7 (2013)

volume 6, 2013

Stefan G Spitzer
[More courage to reform]. Clinical research in cardiology supplements 6 (2013)
B Lüderitz
[On the history of heart failure]. Clinical research in cardiology supplements 6 (2013)
Hermann Fischer
[Diabetes, sport and exercise]. Clinical research in cardiology supplements 6 (2013)
Annett Stahn, Markolf Hanefeld
[Multimodal therapy of dyslipidemia]. Clinical research in cardiology supplements 6 (2013)
Rolf Dörr, Reinhardt Sternitzky
[Non-invasive diagnostics of chronic stable coronary artery disease: evidence-based and non-evidence-based diagnostic algorithms]. Clinical research in cardiology supplements 6 (2013)
Clemens Themba Kadalie, Reinhardt Sternitzky
[Exclusion of coronary artery disease using cardiac CT. What impact do CT results have on patient management?]. Clinical research in cardiology supplements 6 (2013)
Oliver Gaemperli, Philipp A Kaufmann
[Cardiac hybrid imaging]. Clinical research in cardiology supplements 6 (2013)
Lenard Conradi, Hermann Reichenspurner
[3-year results of the SYNTAX trial--stent or surgery? A surgeon's perspective]. Clinical research in cardiology supplements 6 (2013)